Male Infertility

0
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

QT
Q TherapeuticsUT - Salt Lake City
1 program
AndrofertiN/A1 trial
Active Trials
NCT03466229CompletedEst. Dec 2016
Aytu BioPharma
Aytu BioPharmaDENVER, CO
1 program
DiagnosticN/A1 trial
Active Trials
NCT02839447WithdrawnEst. Apr 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Aytu BioPharmaDiagnostic
Q TherapeuticsAndroferti

Clinical Trials (2)

NCT02839447Aytu BioPharmaDiagnostic

A Clinical Evaluation of Semen Quality Using the MiOXSYS™ System 2.0

Start: Sep 2025Est. completion: Apr 2026
N/AWithdrawn
NCT03466229Q TherapeuticsAndroferti

Impact of Antioxidant Treatment on DNA Fragmentation Index

Start: Jul 2015Est. completion: Dec 2016
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space